Intensifying daunorubicin in induction for patients with core binding factor leukemia

Int J Hematol. 2006 Dec;84(5):463-4. doi: 10.1532/IJH97.06138.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Antibiotics, Antineoplastic / administration & dosage*
  • Daunorubicin / administration & dosage*
  • Disease-Free Survival
  • Female
  • Humans
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / mortality*
  • Male
  • Middle Aged
  • Remission Induction
  • Survival Rate
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Daunorubicin